Rifaquizinone

A synthetic antibiotic used in the treatment of tuberculosis

Rifaquizinone
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Rifaquizinone is a synthetic antibiotic belonging to the rifamycin class of antibiotics. It is primarily used in the treatment of tuberculosis (TB), a serious infectious disease caused by the bacterium Mycobacterium tuberculosis. Rifaquizinone is known for its potent bactericidal activity against both actively dividing and dormant mycobacterial cells.

Mechanism of Action

Rifaquizinone works by inhibiting the bacterial DNA-dependent RNA polymerase, an enzyme crucial for the transcription of DNA into RNA. By binding to the beta subunit of this enzyme, Rifaquizinone effectively halts the synthesis of RNA, leading to the death of the bacterial cell. This mechanism is similar to other rifamycin antibiotics, such as rifampicin.

Pharmacokinetics

Rifaquizinone is well absorbed from the gastrointestinal tract when administered orally. It is widely distributed throughout the body, including the central nervous system, which is essential for treating tuberculous meningitis. The drug is metabolized in the liver and excreted primarily in the bile, with a small fraction eliminated via the kidneys.

Clinical Use

Rifaquizinone is used in combination with other antitubercular drugs to prevent the development of drug resistance. It is part of the standard treatment regimen for both drug-susceptible and multidrug-resistant tuberculosis. The drug is also being investigated for its potential use in treating leprosy and other mycobacterial infections.

Side Effects

Common side effects of Rifaquizinone include gastrointestinal disturbances, such as nausea and vomiting, as well as hepatotoxicity. Patients may also experience hypersensitivity reactions, including skin rashes and fever. As with other rifamycins, Rifaquizinone can cause a harmless red-orange discoloration of bodily fluids, such as urine and tears.

Drug Interactions

Rifaquizinone is a potent inducer of cytochrome P450 enzymes, which can lead to significant drug interactions. It can reduce the effectiveness of other medications, such as oral contraceptives, anticoagulants, and certain antiretroviral drugs. Careful monitoring and dose adjustments may be necessary when Rifaquizinone is used concomitantly with these medications.

Related Pages

• Rifampicin
• Tuberculosis treatment
• Antibiotic resistance
• Mycobacterium tuberculosis